Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda

Clinical Trial ID NCT01916759

Rank	Title	Journal	Year	PubWeight™‹?›
1	Rapid cloning of high-affinity human monoclonal antibodies against influenza virus.	Nature	2008	10.80
2	Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.	J Exp Med	2011	7.29
3	Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans.	Nat Immunol	2008	7.18
4	Systems biology of vaccination for seasonal influenza in humans.	Nat Immunol	2011	6.09
5	Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion.	Immunity	2011	5.98
6	Response to a monovalent 2009 influenza A (H1N1) vaccine.	N Engl J Med	2009	5.46
7	Compromised B cell responses to influenza vaccination in HIV-infected individuals.	J Infect Dis	2005	2.12
8	Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals.	AIDS	2010	1.87
9	Pulmonary complications of HIV infection. Report of the Fourth NHLBI Workshop.	Am J Respir Crit Care Med	2001	1.23
10	Safety and immunogenicity of influenza vaccination in individuals infected with HIV.	Vaccine	2002	1.12
11	Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients.	J Allergy Clin Immunol	2011	0.85